21.3.2024 09:19:52 CET | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state

Notice is given that the Annual General Meeting of Thor Medical ASA will be held
on 11 April 2024, at 14:00 hours CEST at Advokatfirmaet Selmer, Ruseløkkveien
14, 0251 Oslo.

The full notice with appendices and the recommendation from the Nomination
Committee are attached. The notice and the documents to which it refers are also
available on www.thormedical.no - https://www.thormedical.no.

The Annual General Meeting will be followed by a presentation from Thor
Medical's CEO by Alf Bjørseth. 

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.

CONTACTS

 * Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440,
   brede.ellingseter@thormedical.no 

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

To learn more, visitwww.thormedical.no - https://www.thormedical.no.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/2985/4231/Download%20announcement
%20as%20PDF.pdf

Thor Medical Notice of AGM 2024 norsk.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/2985/4229/Thor%20Medical%20%20Not
ice%20of%20AGM%202024%20norsk.pdf

Thor Medical Notice of AGM 2024 English.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/2985/4230/Thor%20Medical%20%20Not
ice%20of%20AGM%202024%20English.pdf